ClinicalTrials.gg
Sign In

Tauopathies clinical trials

The registry lists 75 studies for Tauopathies across more than 10 countries. 18 are recruiting or about to start. 6 of them are mainly about Tauopathies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Alzheimer Disease: 4,131 studies, 975 open.

Get an email when these change. Save the Tauopathies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
35
Recruiting
15
Terminated
11
Active, not recruiting
5
Status unknown
3
Withdrawn
2

Phase

Phase 2
24
Phase 1
15
Phase 3
8
Early Phase 1
6

Where

United States
39
Canada
15
France
12
United Kingdom
12
Spain
11
Australia
10

Who runs them

Tammie L. S. Benzinger, MD, PhD (5) · University of Pennsylvania (4) · Eli Lilly and Company (4) · AbbVie (4) · Inmune Bio, Inc. (3) · MODAG GmbH (3) · AstraZeneca (3) · Chang Gung Memorial Hospital (2)

What is being tested here

Drugs under test in Tauopathies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
ML-007C202
NIO752102
XENP 1595003
Donepezil023
Emrusolmin003
Tilavonemab003
Flortaucipir003
Lanabecestat033
Izaflortaucipir F-18002
Donanemab011

Coming up

1phase 3 study under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 15 Tauopathies studies recruiting now, 6 (40%) set no upper age limit and 1 (7%) stop at 75 or younger. 1 (7%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 8 (53%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
101 (7%)1 (7%)
187 (47%)7 (47%)
307 (47%)7 (47%)
4011 (73%)11 (73%)
5013 (87%)13 (87%)
6515 (100%)15 (100%)
7515 (100%)15 (100%)
8512 (80%)12 (80%)

Across all 75 studies, recruiting or not: 12% stop at 75 or younger and 5% at 65; 3% take children; 0% are for women only and 1% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Tauopathies studies take

Of 12 phase 2 interventional studies under Tauopathies, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 233 mo22–39 · 12 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 75. Browse all 75 → or search them.